| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 821 |
| 1 | CENEGERMIN-BKBJ | 800 |
| 2 | CYCLOSPORINE | 612 |
| 3 | ACETAMINOPHEN | 580 |
| 4 | ASPIRIN | 557 |
| 5 | ADALIMUMAB | 550 |
| 6 | ASPIRIN 81 MG | 544 |
| 7 | ASPIRIN 325 MG | 543 |
| 8 | PAIN RELIEVER | 384 |
| 9 | ACETAMINOPHEN 500MG | 383 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ESCHERICHIA COLI | 220 | 0.5598 |
| 1 | POTASSIUM IODIDE | 217 | 0.1471 |
| 2 | CHLOROPROCAINE HYDROCHLORIDE OPHTHALMIC GEL | 7 | 0.0673 |
| 3 | PENTOXIFYLLINE | 231 | 0.0537 |
| 4 | CODEINE SULFATE | 168 | 0.0510 |
| 5 | ACOLTREMON | 189 | 0.0437 |
| 6 | CYCLOSPORINE OPHTHALMIC SOLUTION | 202 | 0.0406 |
| 7 | ALISKIREN HEMIFUMARATE | 232 | 0.0387 |
| 8 | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | 22 | 0.0359 |
| 9 | MINERAL OIL, PETROLATUM | 23 | 0.0354 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1069 |
| 1 | Corticosteroid [EPC] | 859 |
| 2 | Interleukin-4 Receptor alpha Antagonist [EPC] | 821 |
| 3 | Calcineurin Inhibitor Immunosuppressant [EPC] | 817 |
| 4 | Recombinant Human Nerve Growth Factor [EPC] | 800 |
| 5 | HMG-CoA Reductase Inhibitor [EPC] | 598 |
| 6 | Prostaglandin Analog [EPC] | 579 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 572 |
| 8 | Proton Pump Inhibitor [EPC] | 517 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 479 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Recombinant Human Nerve Growth Factor [EPC] | 800 | 0.0665 |
| 1 | Blood Viscosity Reducer [EPC] | 231 | 0.0537 |
| 2 | TRPM8 Thermoreceptor Agonist [EPC] | 189 | 0.0437 |
| 3 | Polyene Antimicrobial [EPC] | 12 | 0.0302 |
| 4 | Semifluorinated Alkane [EPC] | 50 | 0.0261 |
| 5 | Plasma Volume Expander [EPC] | 61 | 0.0203 |
| 6 | Bispecific HER2-directed Antibody [EPC] | 1 | 0.0196 |
| 7 | Ectoparasiticide [EPC] | 55 | 0.0178 |
| 8 | Carbonic Anhydrase Inhibitor [EPC] | 354 | 0.0177 |
| 9 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 255 | 0.0157 |